Dimensional Fund Advisors’s Allogene Therapeutics ALLO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.09M | Sell |
2,736,419
-443,434
| -14% | -$501K | ﹤0.01% | 2644 |
|
2025
Q1 | $4.64M | Sell |
3,179,853
-381,773
| -11% | -$558K | ﹤0.01% | 2515 |
|
2024
Q4 | $7.59M | Buy |
3,561,626
+831,146
| +30% | +$1.77M | ﹤0.01% | 2409 |
|
2024
Q3 | $7.65M | Buy |
2,730,480
+179,840
| +7% | +$504K | ﹤0.01% | 2391 |
|
2024
Q2 | $5.94M | Buy |
2,550,640
+507,021
| +25% | +$1.18M | ﹤0.01% | 2435 |
|
2024
Q1 | $9.13M | Buy |
2,043,619
+508,374
| +33% | +$2.27M | ﹤0.01% | 2344 |
|
2023
Q4 | $4.93M | Sell |
1,535,245
-303,111
| -16% | -$973K | ﹤0.01% | 2563 |
|
2023
Q3 | $5.83M | Buy |
1,838,356
+546,215
| +42% | +$1.73M | ﹤0.01% | 2484 |
|
2023
Q2 | $6.42M | Sell |
1,292,141
-757,115
| -37% | -$3.76M | ﹤0.01% | 2442 |
|
2023
Q1 | $10.1M | Sell |
2,049,256
-340,848
| -14% | -$1.68M | ﹤0.01% | 2227 |
|
2022
Q4 | $15K | Buy |
2,390,104
+655,317
| +38% | +$4.12K | ﹤0.01% | 2002 |
|
2022
Q3 | $18.7M | Buy |
1,734,787
+480,099
| +38% | +$5.18M | 0.01% | 1872 |
|
2022
Q2 | $14.3M | Buy |
1,254,688
+448,701
| +56% | +$5.12M | 0.01% | 2037 |
|
2022
Q1 | $7.34M | Buy |
805,987
+61,259
| +8% | +$558K | ﹤0.01% | 2414 |
|
2021
Q4 | $11.1M | Buy |
744,728
+403,573
| +118% | +$6.02M | ﹤0.01% | 2269 |
|
2021
Q3 | $8.77M | Buy |
341,155
+319,311
| +1,462% | +$8.21M | ﹤0.01% | 2387 |
|
2021
Q2 | $570K | Hold |
21,844
| – | – | ﹤0.01% | 3138 |
|
2021
Q1 | $771K | Sell |
21,844
-23,509
| -52% | -$830K | ﹤0.01% | 3058 |
|
2020
Q4 | $1.15M | Sell |
45,353
-3,195
| -7% | -$80.7K | ﹤0.01% | 2952 |
|
2020
Q3 | $1.83M | Buy |
+48,548
| New | +$1.83M | ﹤0.01% | 2768 |
|
2020
Q1 | – | Sell |
-18,373
| Closed | -$477K | – | 3375 |
|
2019
Q4 | $477K | Sell |
18,373
-576
| -3% | -$15K | ﹤0.01% | 3140 |
|
2019
Q3 | $516K | Buy |
+18,949
| New | +$516K | ﹤0.01% | 3131 |
|